Angiogenesis plays a central role in human physiology from reproduction and fetal development
to wound healing and tissue repair/regeneration. Clinically relevant therapies are needed for
promoting angiogenesis in order to supply oxygen and nutrients after transplantation, thus relieving the
symptoms of ischemia. Increase in angiogenesis can lead to the restoration of damaged tissues, thereby
leading the way for successful tissue regeneration. Tissue regeneration is a broad field that has shown
the convergence of various interdisciplinary fields, wherein living cells in conjugation with biomaterials
have been tried and tested on to the human body. Although there is a prevalence of various approaches
that hypothesize enhanced tissue regeneration via angiogenesis, none of them have been successful
in gaining clinical relevance. Hence, the current review summarizes the recent cell-based and
cell free (exosomes, extracellular vesicles, micro-RNAs) therapies, gene and biomaterial-based approaches
that have been used for angiogenesis-mediated tissue regeneration and have been applied in
treating disease models like ischemic heart, brain stroke, bone defects and corneal defects. This review
also puts forward a concise report of the pre-clinical and clinical studies that have been performed so
far; thereby presenting the credible impact of the development of biomaterials and their 3D concepts in
the field of tissue engineering and regeneration, which would lead to the probable ways for heralding
the successful future of angiogenesis-mediated approaches in the greater perspective of tissue engineering
and regenerative medicine.